J&JPRD Gets FDA Approval for Concerta Adult ADHD

J&JPRD, a drug discovery and drug development company and part of Johnson & Johnson, announced … that the company has received approval from the US Food and Drug Administration (FDA) for its Supplemental New Drug Application (sNDA) for CONCERTA (methylphenidate HCI) extended-release tablets for ADHD in adults ages 18 to 65.
TradingMarkets